- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00064597
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY)
Study Overview
Status
Conditions
Detailed Description
Fetal cells can be recovered from maternal blood, suggesting that noninvasive prenatal diagnosis is possible. However, recovery and analysis of fetal cells from maternal blood is complex and sensitivity is low because of the rarity of these cells in the maternal circulation. This study was designed to develop a noninvasive, safe, relatively inexpensive, and accurate technique for the prenatal diagnosis of genetic disorders in the first trimester.
The study included a systematic evaluation of variables involved in separating and enriching fetal cells isolated from maternal blood through fluorescence activated cell sorting (FACS) and magnetic activated cell sorting (MACS) followed by fluorescent in situ hybridization (FISH) with chromosome-specific DNA probes. The results of these tests were compared to those obtained from amniocentesis or chorionic villus sampling (CVS) on the same women. No clinical decision was made based on the results of the experimental diagnostic/screening technique.
Even if the biological risks associated with reproductive genetic technologies are reduced, it is possible that other risks (or benefits) are associated with the procedures. Some of these factors may be: increased or diminished maternal anxiety, increased adjustment or maladaption to the pregnancy, increased feelings of coercion to undertake the procedure, and increased or decreased comfort with reproductive decision-making. The study also assessed whether there were any nonbiological or psychological effects on the women undergoing prenatal diagnostic testing.
After the first five years of the study, preliminary analysis of the data showed that the sensitivity of aneuploidy detection using fetal cell analysis from maternal blood is comparable to single marker prenatal serum screening, but technological advances are needed before fetal cell analysis has clinical application as part of a multiple maker method for noninvasive prenatal screening. Target cell recovery and fetal cell detection were better using MACS than with FACS. The detection rate of finding at least one aneuploid cell in cases of fetal aneuploidy was 74.4%.
Study Type
Enrollment
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States
- University of Illinois at Chicago
-
-
Massachusetts
-
Boston, Massachusetts, United States
- New England Medical Center Hospital
-
-
Michigan
-
Detroit, Michigan, United States
- Wayne State University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107-5563
- Jefferson Medical College
-
-
Texas
-
Houston, Texas, United States
- Baylor College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Pregnant
- Abnormal serum marker profile (alpha-fetoprotein, hCG, estriol)
- Ultrasound abnormalities of the fetus
- Any high risk indicator for aneuploidy as determined by physician
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Principal Investigator: Laird Jackson, MD
- Principal Investigator: Diana Bianchi, MD
- Principal Investigator: Mark Evans, MD
- Principal Investigator: Sherman Elias, MD
Publications and helpful links
General Publications
- Bischoff FZ, Hahn S, Johnson KL, Simpson JL, Bianchi DW, Lewis DE, Weber WD, Klinger K, Elias S, Jackson LG, Evans MI, Holzgreve W, de la Cruz F. Intact fetal cells in maternal plasma: are they really there? Lancet. 2003 Jan 11;361(9352):139-40. doi: 10.1016/S0140-6736(03)12191-5.
- Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, Dukes KA, Sullivan LM, Klinger KW, Bischoff FZ, Hahn S, Johnson KL, Lewis D, Wapner RJ, de la Cruz F. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn. 2002 Jul;22(7):609-15. doi: 10.1002/pd.347.
- Bianchi DW. Prenatal exclusion of recessively inherited disorders: should maternal plasma analysis precede invasive techniques? Clin Chem. 2002 May;48(5):689-90. No abstract available.
- Bohmer RM, Stroh HP, Johnson KL, LeShane ES, Bianchi DW. Fetal cell isolation from maternal blood cultures by flow cytometric hemoglobin profiles. Results of a preliminary clinical trial. Fetal Diagn Ther. 2002 Mar-Apr;17(2):83-9. doi: 10.1159/000048014.
- Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW, Bianchi DW. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol. 2002 Nov;187(5):1217-21. doi: 10.1067/mob.2002.127462.
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- Prenatal diagnosis
- Magnetic activated cell sorting (MACS)
- Fluorescence in situ hybridization (FISH)
- Fetal cells
- Cytogenetic disorders
- Chromosomal disorders
- Single gene mutation detection
- Abnormal serum marker profile
- Fluorescence activated cell sorting (FACS)
- Chromosomal disorders of the fetus
- Single gene defects of the fetus
Additional Relevant MeSH Terms
Other Study ID Numbers
- NICHD-NIFTY
- 1N01HD43201
- 1N01HD43202
- 1N01HD43203
- 1N01HD43204
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chromosome Disorders
-
Instituto BernabeuCompleted
-
IgenomixCompletedAneuploidy | Chromosome AbnormalityItaly
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedAnxiety | Knowledge, Attitudes, Practice | Decision Making | Chromosome AbnormalityTurkey
-
Shanghai First Maternity and Infant HospitalChildren's Hospital of Fudan University; International Peace Maternity and...UnknownTwin Pregnancy With Antenatal Problem | Chromosome Abnormality
-
Al Baraka Fertility HospitalIbn Sina Hospital; Sadat City UniversityCompletedGenetic Diseases, Inborn | Mutation | Chromosome Abnormalities
-
IgenomixCompletedInfertility | Aneuploidy | Chromosome AbnormalityMexico, Turkey, United States, Argentina, Spain, Brazil, Italy, Peru
-
Assisting NatureRecruitingInfertility | Aneuploidy | Chromosome AbnormalityGreece
-
Assisting NatureRecruitingInfertility | Aneuploidy | Chromosome AbnormalityGreece
-
IgenomixRecruitingInfertility | Aneuploidy | Chromosome AbnormalityFrance, Argentina, Spain, United States, Brazil, Italy
-
University of Colorado, DenverCompletedKlinefelter Syndrome | 47,XXY | Sex Chromosome Aneuploidy | XXY SyndromeUnited States